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cute transitions in cytosolic calcium ([Ca
 
2
 
 
 
]i)
through store-operated calcium entry channels
catalyze interendothelial cell gap formation that
increases permeability. However, the rise in [Ca
 
2
 
 
 
]i only
disrupts barrier function in the absence of a rise in cAMP.
Discovery that type 6 adenylyl cyclase (AC
 
6
 
; EC 4.6.6.1) is
inhibited by calcium entry through store-operated calcium
entry pathways provided a plausible explanation for how
 
inﬂammatory [Ca
 
2
 
 
 
]i mediators may decrease cAMP
 
necessary for endothelial cell gap formation. [Ca
 
2
 
 
 
]i mediators
only modestly decrease global cAMP concentrations and
thus, to date, the physiological role of AC
 
6
 
 is unresolved.
Present studies used an adenoviral construct that expresses
A
 
the calcium-stimulated AC
 
8
 
 to convert normal calcium
inhibition into stimulation of cAMP, within physiologically
relevant concentration ranges. Thrombin stimulated a dose-
dependent [Ca
 
2
 
 
 
]i rise in both pulmonary artery (PAECs)
and microvascular (PMVEC) endothelial cells, and promoted
intercellular gap formation in both cell types. In PAECs,
gap formation was progressive over 2 h, whereas in PMVECs,
gap formation was rapid (within 10 min) and gaps resealed
within 2 h. Expression of AC
 
8
 
 resulted in a modest calcium
stimulation of cAMP, which virtually abolished thrombin-
induced gap formation in PMVECs. Findings provide the
ﬁrst direct evidence that calcium inhibition of AC
 
6
 
 is essential
for endothelial gap formation.
 
Introduction
 
Endothelial cells form a semipermeable barrier that separates
circulating blood elements from underlying tissue (Moore et
al., 1998; Michel and Curry, 1999). Cell shape and, conse-
quently, barrier function are maintained by a balance of
forces (Chicurel et al., 1998; Wang et al., 2001). Centripetally
directed tension is generated by actomyosin motor function
(Kolodney and Wysolmerski, 1992; Sheldon et al., 1993;
Garcia et al., 1995, 1996; Garcia and Schaphorst, 1995;
Goeckeler and Wysolmerski, 1995; Moy et al., 1996;
Bodmer et al., 1997), and is opposed by adhesive proteins at
the cell–cell border and focal adhesions at the cell–matrix
border (Dejana et al., 1999; Michel and Curry, 1999; Yuan,
2000; Bazzoni and Dejana, 2001). Inflammatory mediators,
which act by elevating [Ca
 
2
 
 
 
]i, both increase tension and
decrease adhesion important for the generation of focal
intercellular gaps that form a paracellular pathway to pro-
mote fluid, solute, and protein permeability (Moore et al.,
1998; Michel and Curry, 1999). Physiological transitions in
cytosolic calcium ([Ca
 
2
 
 
 
]i) through store-operated calcium
 
entry pathways trigger gap formation, although [Ca
 
2
 
 
 
]i-
dependent targets that mediate the change in cell shape are
poorly understood.
Inflammatory [Ca
 
2
 
 
 
]i agonists only increase permeability
in the absence of a rise in cAMP (Carson et al., 1989;
Casnocha et al., 1989; Minnear et al., 1989; Morel et al.,
1989; Stelzner et al., 1989; Allsup and Boarder, 1990;
Oliver, 1990). cAMP-elevating agents improve constitutive
barrier function and prevent the endothelial cell disruption
that occurs in response to a rise in [Ca
 
2
 
 
 
]i. Moreover, either
inhibition of cAMP synthesis or its protein kinase (e.g.,
PKA) is sufficient to decrease adhesion and increase perme-
ability (Stelzner et al., 1989; Stevens et al., 1995), suggesting
that cAMP primarily regulates sites of cell–cell tethering.
These findings bring into question the independent roles of
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[Ca
 
2
 
 
 
]i and cAMP in endothelial cell barrier disruption. Re-
sults from cloning and expression of a calcium-inhibited ade-
nylyl cyclase (type 6 adenylyl cyclase [AC
 
6
 
]*) in nonexcitable
cells provided a plausible mechanism through which inflam-
matory [Ca
 
2
 
 
 
]i agonists could decrease cAMP (Yoshimura
and Cooper, 1992). Endothelial cells express AC
 
6
 
 as deter-
mined by in vivo (Chetham et al., 1997; Jourdan et al.,
2001) and in vitro assays (Manolopoulos et al., 1995a,b;
Stevens et al., 1995, 1997, 1999; unpublished data). Submi-
cromolar calcium concentrations decrease cAMP accumula-
tion by 
 
 
 
30% in endothelial cell membranes (Stevens et al.,
1995), and activation of store-operated calcium entry de-
creases cAMP and PKA activity 30–50% in intact cells
(Stevens et al., 1995, 1997, 1999; unpublished data). Thus,
calcium inhibition of AC
 
6
 
 may importantly contribute to en-
dothelial cell gap formation.
Evidence for regulation of endothelial cell barrier function
by AC
 
6
 
 is indirect and has been hampered by the inability to
specifically control cAMP concentrations within a physio-
logically relevant range. A mechanism(s) accounting for cal-
cium inhibition of AC
 
6
 
 is unresolved (Guillou et al., 1999;
Gu and Cooper, 2000), although calcium inhibition does
not require calmodulin or other calcium binding proteins
(Caldwell et al., 1992). Recent studies suggest the presence
of two distinct calcium binding sites on AC
 
6
 
, with apparent
high and low affinities (Guillou et al., 1999; Gu and Coo-
per, 2000). Presumably the high affinity binding site ac-
counts for enzyme calcium inhibition, because even cal-
cium-insensitive isoforms of AC possess a low affinity
binding site that inhibits enzyme activity at millimolar
calcium concentrations. Structural assignment of the high
affinity binding site is incomplete, making site-directed
 
mutagenesis an untenable approach to evaluate the physio-
logical role of AC
 
6
 
.
Fagan et al. (2000a) recently developed an adenovirus that
expresses a calcium calmodulin–stimulated (AC
 
8
 
) enzyme. In
their studies, adenovirus infection resulted in significant AC
 
8
 
expression in the excitable GH
 
4
 
C
 
1
 
 cell type. Enzyme activity
was intimately regulated by calcium entry through store-oper-
ated calcium entry pathways, relatively insensitive to regula-
tion by calcium entry through voltage-gated calcium chan-
nels, and not stimulated by calcium release from intracellular
stores. Their findings indicated that calcium-sensitive ACs
functionally colocalize with store-operated calcium entry
pathways (Fagan et al., 1996, 1998, 2000b), and also demon-
strated that AC
 
8
 
 expression may represent a tenable approach
to reversing the endogenous calcium inhibition of AC
 
6
 
. Pres-
ently, we used the adenoviral construct that expresses AC
 
8
 
 to
examine the physiological role of endogenously expressed AC
 
6
 
in nonexcitable endothelial cells. Our results indicate that
thrombin-induced gap formation only proceeds when a rise in
[Ca
 
2
 
 
 
]i inhibits AC
 
6
 
 and is not observed when a rise in
[Ca
 
2
 
 
 
]i stimulates AC
 
8
 
. These results provide the first direct
evidence that calcium inhibition of AC
 
6
 
 plays a central, domi-
nant role in regulation of intercellular gap formation.
 
Results
 
Thrombin-induced [Ca
 
2
 
 
 
]i responses in lung 
macro- and microvascular endothelium
 
Lung macro- and microvascular endothelial cells exhibit dis-
tinct [Ca
 
2
 
 
 
]i regulatory properties (Stevens et al., 1997), al-
though the relative [Ca
 
2
 
 
 
]i responses to G
 
q
 
-linked agonists
are poorly understood. We therefore used pulmonary artery
(PAECs) and microvascular endothelial cells (PMVECs) to
examine thrombin-activated [Ca
 
2
 
 
 
]i signaling. In PAECs,
thrombin induced a typical peak in [Ca
 
2
 
 
 
]i that was due to
calcium release from intracellular stores, followed by calcium
 
*Abbreviations used in this paper: AC, adenylyl cyclase; InsP
 
3
 
, inositol
1,4,5-triphosphate; PAEC, pulmonary artery endothelial cell; PMVEC,
pulmonary microvascular endothelial cell; YFP, yellow fluorescent protein.
Figure 1. Thrombin produces a bell shape [Ca
2 ]i dose-dependent curve in PAECs. (A) Individual traces reveal that thrombin initiates 
[Ca
2 ]i signaling at concentrations below 0.01 U/ml, and reaches a maximal response at 1 U/ml. Higher thrombin concentrations reduce 
both calcium release (peak height) and entry (sustained plateau) phases. Indeed, in response to 100 U/ml thrombin, [Ca
2 ]i drops below 
constitutive levels during the “entry” phase, indicating pronounced inhibition of entry or stimulation of extrusion. Units on the y axis scale 
represent the ratio of calcium-bound (340 nm) to -unbound (380 nm) wavelengths for fura-2 fluorescence. Calcium release (B and D) and 
entry (C and D) phases are summarized, and are representative of n   3–8/treatment. Area (AU, arbitrary units) on the y axis scale represents 
the relative area under the curve (e.g., above baseline values) generated during the Ca
2  entry phase. 
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entry across the cell membrane (Fig. 1 A). Thrombin-
induced calcium release occurs in response to inositol 1,4,5-
trisphosphate (InsP
 
3
 
) production that activates InsP
 
3
 
 recep-
tors in the endoplasmic reticulum; the magnitude of this
release phase is not influenced by acutely reducing extracel-
lular calcium (Stevens et al., 1997). Calcium entry across the
cell membrane occurs after calcium store depletion due to
activation of store- and receptor-operated calcium channels
(Putney, 1986).
Dose response curves revealed that 1 U/ml thrombin max-
imally activated both calcium release and entry in PAECs,
indicating direct coupling between calcium store depletion
and calcium entry through store-operated calcium entry
pathways (Fig. 1, B–D). The correlation between calcium re-
lease and entry was exact until 1 U/ml thrombin. At higher
thrombin concentrations (100 U/ml), however, calcium re-
lease was reduced to 30% of its maximal response and cal-
cium entry was 25% below basal levels. The thrombin
[Ca
 
2
 
 
 
]i dose response was bell shaped, suggesting that higher
thrombin concentrations, in particular, activated interrelated
regulatory pathways. These findings are generally compatible
with thrombin’s simultaneous activation of multiple signal-
ing pathways (Molino et al., 1997). Because the correlation
between calcium release and entry was not apparent at high
thrombin concentrations, these data suggest that thrombin
activated feedback inhibition of calcium entry channels.
The thrombin-induced [Ca
 
2
 
 
 
]i responses were different in
PMVECs than in PAECs. Thrombin induced a sigmoidal
[Ca
 
2
 
 
 
]i dose response curve in PMVECs, both in calcium re-
lease and entry (Fig. 2). There was good association between
calcium release and entry over the entire dose range (Fig. 2
D), generally compatible with the mechanism of store-oper-
ated calcium entry. PMVECs were more sensitive to throm-
bin than were PAECs. Even though thrombin did not initiate
a [Ca
 
2
 
 
 
]i rise in PMVECs until 0.1 U/ml (versus 0.01 U/ml
in PAECs), the microvascular cell dose response curve was left
shifted, indicating greater thrombin sensitivity; in PMVECs
the EC
 
50
 
 
 
 
 
 0.05 U/ml and in PAECs the EC
 
50
 
 
 
 
 
 0.1 U/ml.
Calcium release and entry coupling was not similar be-
tween PMVECs and PAECs. Even though good associa-
tion between calcium release and entry was observed in
PMVECs, these findings are incompatible with the notion
that store-operated calcium entry pathways represent the
predominant mode of calcium entry in microvascular cells.
Peak calcium release was 
 
 
 
40% lower in PMVECs than in
PAECs, suggesting that either thrombin does not equiva-
lently stimulate InsP
 
3
 
 production in both cell types or that
InsP
 
3
 
 does not equivalently stimulate calcium release in
PMVECs. Prior work supports the latter possibility; InsP
 
3
 
is rapidly hydrolyzed in cytosol (Ribeiro et al., 1997)
and we have recently demonstrated that the endoplasmic
reticulum is twofold farther from the plasmalemma in
PMVECs (
 
 
 
250 nm) than in PAECs (
 
 
 
100 nm) (unpub-
lished data). Although not specifically examined in the
present study, a decrease in thrombin-induced calcium re-
lease may result from hydrolysis of InsP
 
3
 
 before receptor
binding. Although thrombin-induced calcium release was
lower in PMVECs than in PAECs, the calcium entry re-
sponse was 
 
 
 
30% higher (Fig. 3). Thus, although calcium
store depletion and calcium entry correlate within a cell
type, the magnitude of calcium release and entry are not
associated between cell types.
Figure 2. Thrombin produces a sigmoidal [Ca
2 ]i dose-dependent 
curve in PMVECs. (A) Individual traces reveal that thrombin initiates 
[Ca
2 ]i signaling at concentrations near 0.01 U/ml, and reaches a 
maximal response near 0.1 U/ml. This maximal [Ca
2 ]i response is 
sustained after application of higher thrombin concentrations. 
Indeed, the [Ca
2 ]i response to 0.1 and 10 U/ml thrombin are 
nearly identical. Units on the y axis scale represent the ratio of 
calcium-bound (340 nm) to -unbound (380 nm) wavelengths for 
fura-2 fluorescence. Calcium release (B and D) and entry (C and D) 
phases are summarized, and are representative of n   3–4/treatment. 
Area (AU, arbitrary units) on the y axis scale represents the relative 
area under the curve (e.g., above baseline values) generated during 
the Ca
2  entry phase.
Figure 3. Coupling between Ca
2  store depletion and activation 
of Ca
2  entry is dissimilar between PAECs and PMVECs. Whereas 
maximal thrombin-induced Ca
2  release is greater in PAECs, maximal 
Ca
2  entry is elevated in PMVECs (n   3/treatment). An asterisk 
denotes significant difference from corresponding PAEC value. 
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Thrombin produces homologous desensitization of its re-
ceptor(s), resulting in decreased [Ca
 
2
 
 
 
]i signaling, inhibition
of protein phosphorylation, and preservation of endothelial
cell barrier function (Brass et al., 1991; Levin and Santell,
1991; Weintraub et al., 1992; Kruse et al., 1995; Yan et
al., 1998). Maximal or near-maximal thrombin doses are
typically used for desensitization studies. We examined
whether lower thrombin concentrations desensitize subse-
quent [Ca
 
2
 
 
 
]i responses to EC
 
100
 
 thrombin concentrations.
Fig. 4, A, C, and D, illustrates that an EC
 
20
 
 concentration of
thrombin effectively desensitizes PAECs to subsequent acti-
vation by maximal doses. In PMVECs, similar low concen-
trations of thrombin only reduced the maximal response by
40%, indicating that 0.01 U/ml was insufficient to fully de-
sensitize thrombin-induced [Ca
 
2
 
 
 
]i signaling in microvascu-
lar cells. However, 0.1 U/ml thrombin induced a large
[Ca
 
2
 
 
 
]i rise and abolished the subsequent [Ca
 
2
 
 
 
]i response
to maximal thrombin concentrations in PMVECs (Fig. 4,
B–D). Thus, thrombin-induced calcium entry is abolished
by receptor desensitization, as it is in the presence of nomi-
nal extracellular calcium.
 
Thrombin-induced endothelial cell gap formation
 
Thrombin disrupts the endothelial cell barrier and increases
macromolecular, solute, and water permeability (Casnocha
et al., 1989; Minnear et al., 1989; Lum et al., 1993; Garcia
et al., 1995, 1996; Garcia and Schaphorst, 1995; Bartha et
al., 2000; Moore et al., 2000; Norwood et al., 2000). Barrier
disruption is induced by an increase in centripetally directed
tension that is mediated through the activation of an acto-
myosin-based motor, and by a decrease in cell adhesion that
is mediated through the loss of cadherin-dependent cell–cell
tethering. Signaling events that promote increased tension
and decreased adhesion are incompletely understood, though
calcium entry across the cell membrane is recognized as an
important catalyst (Moore et al., 1998). Despite the implied
role of increased [Ca
 
2
 
 
 
]i in the loss of endothelial cell barrier
function, prior studies have not distinguished between
[Ca
 
2
 
 
 
]i-dependent signaling events and simultaneous activa-
tion of other signaling pathways, particularly in macro- and
microvascular endothelia. We therefore examined the spe-
cific role of thrombin-induced calcium signaling in PAECs
and PMVECs.
Fig. 5 illustrates thrombin-induced gap formation in
PAECs and PMVECs. Acute application of 1 U/ml (EC
 
100
 
)
thrombin to PAEC monolayers produced small gaps be-
tween cells that resealed over a 1-h time course (Fig. 5 A).
Gaps were difficult to clearly resolve by light microscopy,
though they were evident by the appearance of translucent
cell–cell borders. These findings are compatible with prior
studies indicating that increased macromolecular permeabil-
ity occurs through only minor ultrastructural disturbances in
adherens junctions (McDonald et al., 1999; Moy et al.,
2000). Higher thrombin concentrations (100 U/ml) pro-
duced larger, more visible intercellular gaps that persisted
and, indeed, increased over a 2-h time course (Fig. 5, B and
D). Because [Ca
2 ]i responses are lower in response to 100
U/ml than to 1 U/ml thrombin (Fig. 1 D), these data indi-
cate that the large gaps generated in response to higher
thrombin concentrations occur after activation of calcium-
independent signaling pathways.
Our prior studies indicated that direct activation of store-
operated calcium entry did not increase PMVEC permeabil-
ity (Kelly et al., 1998). Similarly, in the intact pulmonary
circulation, thapsigargin did not induce intercellular gaps in
small arteries, veins, or capillaries, but gap formation was
prominent in large arteries and veins (Chetham et al., 1999).
In our present study, thrombin (EC100) induced gap forma-
tion in cultured PMVECs, though unlike conduit cells, the
response was not sustained (Fig. 5, C–E). Indeed, gaps that
formed in PMVECs rapidly resealed; these findings are illus-
trated in the supplementary video (Video 1, available on-
line at http://www.jcb.org/cgi/content/full/jcb.200204022/
DC1) that accompanies Fig. 5 C. A 1-h time course is com-
pressed to  45 s in the video. Gaps were fully formed 5–10
Figure 4. Low thrombin concentrations acutely desensitize [Ca
2 ]i 
signaling. (A) Application of an EC20 thrombin dose acutely abolishes 
the subsequent [Ca
2 ]i response to an EC100 thrombin concentration 
in PAECs. Similar inhibition was not observed in PMVECs (unpublished 
data). Units on the y axis scale represent the ratio of calcium-bound 
(340 nm) to -unbound (380 nm) wavelengths for fura-2 fluorescence. 
(B) Application of an EC100 thrombin concentration acutely reduces 
the subsequent [Ca
2 ]i response to a higher thrombin dose in 
PMVECs. Summary data are shown for Ca
2  release (C) and entry 
(D) phases, and are representative of n   3/treatment. Area (AU, 
arbitrary units) on the y axis scale represents the relative area under 
the curve (e.g., above baseline values) generated during the Ca
2  
entry phase.AC6 and endothelial cell gap formation | Cioffi et al. 1271
min after thrombin application and subsequently resealed
within 1–2 h.
Thrombin induced PAEC and PMVEC gaps that varied
in size, though clearly the largest gaps were observed in
PMVECs. A direct comparison between cell types is shown
in Fig. 5 D, where equivalent gap sizes are plotted. Whereas
gap size progressively increased over 2 h in PAECs, gap size
progressively decreased after 10 min in PMVECs. As shown
in Fig. 5 E, even the largest PMVEC gaps were nearly
completely resealed by 2 h. These findings indicate that
PMVECs possess a unique capacity to repair or reseal inter-
cellular gaps, even in the continued presence of thrombin.
Calcium-sensitive ACs and endothelial 
cell gap formation
Because thrombin activates multiple intracellular signaling
cascades, we sought to examine the specific role of [Ca
2 ]i in
gap formation. In PAECs, low thrombin concentrations
(0.01 U/ml; EC20) desensitized the subsequent [Ca
2 ]i re-
sponse to maximal doses (1.0 U/ml). In PMVECs, higher
thrombin doses (0.10 U/ml) were required to desensitize
subsequent [Ca
2 ]i responses. However, the use of higher
concentrations elicited a large [Ca
2 ]i response and therefore
the desensitization approach could not resolve between
[Ca
2 ]i-dependent and -independent signal transduction
Figure 5. Thrombin induces interendothelial cell gap formation in PAECs 
and PMVECs, although only gaps in PMVECs reseal within 2 h. (A) In basal 
PAEC monolayers (i), application of 1 U/ml thrombin induced intercellular 
gaps within 10 min (ii) that persisted over 60 (iii) and 120 (iv) min, though gaps 
were difficult to clearly resolve by light microscopy. Gaps are seen as translucent 
borders indicated by arrows in ii–iv. (B) To more clearly resolve gaps, PAECs 
were grown to confluence (i) and 100 U/ml thrombin was applied. Gaps 
apparent at 10 min (ii) were sustained over 30 (iii) and 60 (iv) min. (C) Application 
of 100 U/ml thrombin to PMVECs (i) resulted in the formation of large gaps at 10 min (ii) that were easily resolved. In contrast to PAECs, gaps 
in PMVECs resealed over 30 (iii) and 60 (iv) min. See Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200204022/DC1. (D) Direct 
comparison of gaps between cell types reveals that whereas gap size increases temporally in PAECs, gap size decreases temporally in 
PMVECs. (E) The capacity of PMVECs to reseal their barrier is evident even when large gaps have formed. Arrows indicate intercellular gaps. 
n   6–8/treatment.1272 The Journal of Cell Biology | Volume 157, Number 7, 2002
pathways (Fig. 6, A and B), indicating that more direct ap-
proaches were required to specifically divulge the require-
ment of [Ca
2 ]i in thrombin-induced gap formation.
Though Ca
2  entry is a well-recognized stimulus for en-
dothelial cell barrier disruption, the Ca
2 -sensitive targets
mediating this response are poorly understood. We have
previously reported that Ca
2  entry reduces cAMP in
PAECs, and that the decrease in cAMP contributes to endo-
thelial cell gap formation (Stevens et al., 1995). Indeed, the
inverse relationship between Ca
2  and cAMP is mediated
through AC6, which is specifically inhibited by Ca
2  entry
through store-operated Ca
2  entry pathways (Fagan et al.,
1996, 1998, 2000b). Despite studies implicating AC6 in en-
dothelial barrier disruption, conclusive proof for this idea
has been limited by our inability to specifically control
cAMP levels within the physiological range. The Ca
2 -sensi-
tive region of AC6 is unknown, and thus studies seeking to
specifically eliminate enzyme Ca
2  inhibition are implausi-
ble (Guillou et al., 1999; Gu and Cooper, 2000). Our
present approach therefore exploited an adenovirus vector
constructed to express the Ca
2 -stimulated AC8. Prior work
from Fagan et al. (2000a) established that the AC8/adeno-
virus construct expresses functional enzyme that converts
Ca
2  inhibition into Ca
2  stimulation of cAMP.
Expression of the AC8/adenovirus construct did not
change basal PMVEC cAMP concentrations (control  
124   9 fmol cAMP vs. AC8   120   11 fmol cAMP).
Forskolin and rolipram synergistically increase cAMP in
PMVECs, and allow easy resolution of AC6 Ca
2  inhibition
(Stevens et al., 1999; unpublished data). Similar to our pre-
vious reports (Stevens et al., 1995, 1997, 1999; unpublished
data), thrombin inhibited cAMP in PMVECS that endoge-
nously expressed AC6 (Fig. 7 A). However, in cells express-
ing the AC8/adenovirus construct, the thrombin-induced
Ca
2  inhibition was converted into Ca
2  stimulation of cAMP
(Fig. 7 B). Thus, cells infected with the AC8/adenoviral con-
struct provided the first available model to specifically exam-
ine the physiological role of AC6 in regulation of endothelial
cell barrier apposition.
Remarkably, infection with the AC8/adenoviral construct
nearly abolished thrombin-induced PMVEC gap formation,
shown in Fig. 7, C and D, and the accompanying time-
compressed video (Video 2, available online at http://
www.jcb.org/cgi/content/full/jcb.200204022/DC1). Fig. 7
D summarizes all gaps formed in AC8-expressing cells
treated with thrombin; this figure differs from control exper-
iments (e.g., Fig. 5 D) that standardized gap size between
PAECs and PMVECs. Indeed, Fig. 5 E illustrates PMVEC
gaps that exceeded 15   10
2  m
2 in some cases. Cells in-
fected with the AC8/adenoviral construct possessed very few
gaps that were of low magnitude (e.g.,  2.4   10
2  m
2).
Although even small gaps rarely formed in cells expressing
AC8, the video clearly illustrates that thrombin initiated cell
movement. Thrombin induces myosin light chain phos-
phorylation and increases actomyosin motor function. The
relative contributions of increased motor function and de-
creased cell adhesion to gap formation is still controversial.
However, our data suggest cAMP primarily regulates adhe-
sion as opposed to “contraction,” and suggests that increased
motor function does not form gaps if cell–cell adhesion is
maintained.
It is not clear in AC8-expressing cells how small rises in
global cAMP could, with such strength, oppose thrombin-
induced gap formation. Recent studies (Rich et al., 2000,
2001) implicate discrete cAMP pools, including its site of
synthesis (e.g., plasmalemma) and the bulk cytosol, in loca-
tion-specific function. Thus, AC localization is an important
determinant of enzyme (and cAMP) function independent
of global cAMP concentrations. We examined localization
of AC8 by expressing it as a fusion with yellow fluorescent
protein (YFP). Fig. 8 illustrates nearly uniform expression of
every cell infected with the YFP–AC8/adenoviral construct.
Confocal imaging from abluminal-to-luminal cell aspects re-
veals punctate staining at abluminal and luminal cell aspects,
with staining enrichment at cell–cell borders, suggesting that
the enzyme localizes to sites of cell contact. Indeed, the
video (Video 6) accompanying Fig. 8 E demonstrates dy-
namic movement of YFP–AC8 at sites of cell–cell contact.
As seen in this video, YFP–AC8 localization to cell–cell bor-
ders is retained in accordance with cell movement in re-
sponse to thrombin, including membrane association during
Figure 6. A desensitizing thrombin concentration induces gap 
formation in PMVECs. Application of 0.1 U/ml thrombin increased 
[Ca
2 ]i and desensitized the subsequent response to 10 U/ml thrombin 
(Fig. 4 B). (A) Similar treatment in confluent PMVECs (i) revealed 
that the desensitizing [Ca
2 ]i response to 0.1 U/ml thrombin induced 
gap formation within 10 min (ii), which resolved over 30 (iii) and 60 
(iv) min. (B) Summary of gaps formed by the desensitizing dose of 
thrombin shows resolution of gaps over a 60-min time course. 
Arrows indicate intercellular gaps. n   3/treatment.AC6 and endothelial cell gap formation | Cioffi et al. 1273
small, transient gap formation. Taken together, these data
support the idea that AC localization to sites of cell–cell con-
tact is an important determinant of how localized changes in
calcium-dependent cAMP concentrations regulate intercel-
lular gap formation.
Discussion
Inflammatory [Ca
2 ]i agonists induce interendothelial cell
gaps. However, a rise in [Ca
2 ]i only promotes gap forma-
tion if cAMP levels are not also increased. We have previ-
ously demonstrated that endothelial cells express AC6, and
physiological [Ca
2 ]i transitions through store-operated cal-
cium entry channels reduce enzyme activity (Stevens et al.,
1995, 1997, 1999; unpublished data). In prior studies, acti-
vation of store-operated calcium entry decreased global
cAMP by  30%. We have not firmly established whether a
30% decrease in global cAMP contributes to intercellular
gap formation; indeed, because of difficulties regulating
cAMP within a narrow concentration range, we have hereto-
fore been unable to clearly establish the independent effects
of [Ca
2 ]i and cAMP. Consequently, the physiological sig-
nificance of AC6 was unclear. Use of an adenoviral construct
expressing AC8 has allowed precise control over calcium-reg-
ulated cAMP production. For the first time, our findings di-
rectly implicate AC6 in thrombin-induced endothelial cell
gap formation.
Emerging evidence suggests that PAECs and PMVECs
arise from distinct embryological origins and retain pheno-
typic differences even when their environments are the same
Figure 7. Expression of AC8 prevents thrombin 
from inducing gaps in PMVECs. (A) Confluent 
PMVECs were incubated with the type 4 
phosphodiesterase inhibitor rolipram (10  M) 
for 10 min before thrombin (100 U/ml) treatment. 
5 min after addition of thrombin, PMVECs were 
collected for cAMP determination. Thrombin 
decreased cAMP from 1293   123 to 648   
37 fmol/well, consistent with calcium inhibition 
of endogenous AC6. (B) Expression of AC8 did 
not change basal cAMP concentrations. How-
ever, in cells infected with the AC8/adenovirus 
construct, rolipram (10  M) and thrombin (100 
U/ml) treatment resulted in an increase in 
cAMP, indicating that endogenous calcium 
inhibition had been converted to stimulation 
of AC. (C) Cells expressing the AC8/adenovirus 
construct (i) did not respond to thrombin with 
significant gap formation at 10 (ii), 30 (iii), or 
60 (iv) min. Arrows indicate intercellular gaps. 
See Video 2, available at http://www.jcb.
org/cgi/content/full/jcb.200204022/DC1.
(D) Summary data reveals that thrombin induced few gaps in cells expressing the AC8/adenovirus construct. Gaps that did form were small in 
size and resealed rapidly (n   7/treatment). (E) Cells expressing an alkaline phosphatase/adenovirus construct were used to confirm that adenoviral 
infection and expression, per se, did not provide nonspecific protection against thrombin-induced gap formation. Cells are shown before (i) 
and 10 (ii), 30 (iii), 60 (iv), and 90 (v) min after thrombin stimulation. Arrows indicate intercellular gaps. Video 3 demonstrates that expression 
of alkaline phosphatase does not inhibit thrombin-induced gap formation.1274 The Journal of Cell Biology | Volume 157, Number 7, 2002
(deMello et al., 1997; deMello and Reid, 2000; Stevens et
al., 2001; Maeda et al., 2002). Previous studies using these
cells have demonstrated that their calcium and cyclic nucle-
otide regulatory properties significantly differ (Stevens et al.,
1997, 1999), although they both possess store-operated cal-
cium entry pathways and they both express AC6. PMVECs
form a more restrictive barrier in vivo and in vitro to protect
the alveolar-capillary network from fluid accumulation and
to optimize gas exchange (Kelly et al., 1998; Chetham et al.,
1999). Direct activation of store-operated calcium entry us-
Figure 8. AC8 localizes to sites of cell–cell contact. (A) Subconfluent PMVECs (i) were infected with the YFP–AC8 adenovirus construct (ii). 
Overlay of phase contrast and fluorescent images (iii) reveals that virtually every cell expressed YFP–AC8. The box indicates cells analyzed by 
confocal microscopy in B–D. (B) Abluminal-to-luminal cell slices were analyzed by confocal microscopy at 0.5- m resolution (i–xiv, abluminal 
to luminal). Punctate staining is observed on abluminal and luminal cell aspects, whereas staining enrichment was observed at cell–cell borders. 
Video 4 illustrates the abluminal-to-luminal expression pattern of YFP–AC8. (C) Cell coordinates are shown on the x and y axes. Fluorescent 
intensity is shown on the z axis. Fluorescence intensity is greatest at sites of cell–cell contact. (D) 3-D reconstruction of confocal images taken 
in B demonstrates high fluorescent intensity at sites of cell–cell contact from side (i, arrow denotes AC8 expression at cell–cell borders and 
arrowhead denotes the cell’s luminal aspect), angled (ii, arrowheads denote punctate staining), and horizontal (iii) views. Video 5 shows the 
lateral rotation of the 3-D image. (E) Response of YFP–AC8 was observed after application with thrombin (20 U/ml). Staining is most apparent 
at sites of cell–cell contact (i), and remains most intense at sites of cell–cell contact even after thrombin application for 10 (ii) and 30 (iii) min. 
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ing thapsigargin increases PAEC, but does not increase
PMVEC, macromolecular permeability (Kelly et al., 1998;
Chetham et al., 1999). Our present studies therefore used
the inflammatory [Ca
2 ]i agonist thrombin, which, like
thapsigargin, activates store-operated calcium entry. In addi-
tion, however, thrombin activates Gi and G12/13 signaling
pathways that inhibit AC (Brass et al., 1991) and activate
Rho signaling cascades (Vouret-Craviari et al., 1998; Carba-
jal and Schaeffer, 1999; Carbajal et al., 2000; Sah et al.,
2000; van Nieuw Amerongen et al., 2000a,b; Wojciak-Sto-
thard et al., 2001), respectively. Activation of Rho and its ki-
nase promotes the cytoskeletal reorganization that is impor-
tant for induction of intercellular gap formation.
We found that thrombin induces gap formation in both
PAECs and PMVECs. High thrombin concentrations were
required to break cell–cell adhesions in microvascular cells.
Indeed, our dose response curves were conducted over
thrombin concentrations that exceeded its normal range.
High thrombin concentrations revealed unique responses in
PAECs and PMVECs. Calcium regulatory mechanisms are
different between these cell types at high thrombin concen-
trations; PAECs posses a feedback inhibitory mechanism not
present in PMVECs. In addition, gap formation in PAECs
was slow and progressive, whereas gap formation in PMVECs
was rapid and quickly resolved, suggesting that microvascu-
lar cells possess a motility/repair mechanism not present
in their macrovascular counterparts. The gaps that formed
in PMVECs were substantially larger than those present in
PAECs. While speculative, PMVECs may possess a higher
resting tension so that the disruption of cell–cell adhesion
produces large gaps that form rapidly.
In PAECs, gaps formed in response to the high thrombin
concentrations that also inhibited calcium entry. Thus, in-
tercellular gap formation can be induced by [Ca
2 ]i-inde-
pendent as well as [Ca
2 ]i-dependent signaling cascades.
AC6 is a calcium entry–sensitive target that coordinates
[Ca
2 ]i and cAMP signaling pathways. AC6 functionally
colocalizes with store-operated calcium entry channels (Fa-
gan et al., 1996, 1998, 2000b), indicating that thrombin
may inhibit AC6 activity by stimulating calcium entry and
activating Gi.
Our present studies sought to specifically determine the
relevance of AC6 in thrombin-induced gap formation. De-
spite the activation of multiple signaling pathways, we found
that converting calcium inhibition to modest stimulation of
cAMP nearly abolished thrombin-induced gap formation in
PMVECs. In AC8-expressing cells, AC8 localized to sites of
cell–cell contact. Digitally time-compressed videos revealed
that although AC8-expressing cells did not form gaps, they
still exhibited significant movement that was generally con-
sistent with activation of motor function. It therefore ap-
pears that AC6 decreases the cAMP necessary to break cell–
cell adhesions without significantly altering actomyosin
function per se. cAMP activation of its protein kinase re-
duces endothelial cell myosin light chain kinase activity
(Garcia et al., 1997), indicating that cAMP is capable of re-
ducing endothelial cell motor function. However, our find-
ings suggest that the principal role of calcium-sensitive
cAMP synthesis is not to regulate actomyosin interaction,
but rather to control cell–cell adhesion. In future studies, it
will be important to determine relevant A-kinase targets that
may control development of intercellular gap formation.
In summary, our studies have used two distinct endothe-
lial cell phenotypes, PAECs and PMVECs, to evaluate the
role of AC6 in thrombin-induced gap formation. Thrombin
activates store-operated calcium entry in both cell types,
along with other reported signaling cascades. Nonetheless,
calcium entry across the cell membrane is an important de-
terminant of gap formation. We have established for the first
time that calcium entry is required to inhibit AC6 activity,
which decreases cAMP necessary for generation of intercel-
lular gaps. These findings firmly establish a physiological
role for AC6 in nonexcitable endothelial cells: AC6 critically
regulates gap formation.
Materials and methods
Reagents
All reagents were obtained from Sigma-Aldrich, unless otherwise speci-
fied. Thrombin used in calcium and videomicroscopy experiments was
from Sigma-Aldrich, catalog no. T-6634, lot 19H7612 (from bovine
plasma) or catalog no. T-5772, lot 71K7612 (from rat plasma). Fura-2/AM
and Pluronic
® F-127 were purchased from Molecular Probes.
Isolation and culture of pulmonary endothelial cells
PAECs and PMVECs were isolated and cultured using a method described
in detail by Stevens et al. (1999). Cells were routinely passaged by scrap-
ing. Cultures were characterized using SEM, uptake of 1,1’-dioctadecyl-
3,3,3 ,3 -tetramethylindocarbocyanine–labeled low-density lipoprotein
(DiI-acetylated LDL), and a lectin binding panel.
Construction of the virus expressing AC8
A full-length description of the adenovirus expressing AC8 has been re-
ported in detail elsewhere (Fagan et al., 2000a). However, for construction
of an adenovirus-transducing vector encoding the YFP–AC8 fusion protein,
the YFP–AC8 fusion protein gene was excised from the plasmid pEYFP-C1
by digesting with NheI, filling in with T4 DNA polymerase in the presence
of dNTPs, and digesting with XbaI. The plasmid pShuttleCMV (He et al.,
1998) was digested with XhoI, blunt ended with T4 DNA polymerase in
the presence of dNTPs, and digested with XbaI. The YFP–AC8 gene and
pShuttleCMV fragments were resolved by low melting point agarose gel
electrophoresis, excised, and the DNA fragments were recovered by melt-
ing the agarose followed by phenol extraction and ethanol precipitation.
The DNA fragments were ligated to generate the plasmid pShuttleCMV-
YFP–AC8. The YFP–AC8 gene was removed from pShuttleCMV-YFP–AC8
by digestion with NotI and XbaI and ligated with pShuttleE1A DNA
(Schaack et al., 2001) that had been digested with the same restriction en-
zymes. The shuttle vectors encoding YFP–AC8 were then linearized by di-
gestion with PmeI, and 20 ng of each was used to electroporate Esche-
richia coli strain BJ5183 carrying the plasmid pAdEasy-1(He et al., 1998), a
modification that we previously found helpful for plasmid construction
(Orlicky and Schaack, 2001), to introduce the YFP–AC8 genes into the ade-
novirus chromosome by homologous recombination (Chartier et al., 1996;
Crouzet et al., 1997; He et al., 1998). Resulting colonies were screened by
agarose gel electrophoresis of undigested plasmid DNAs. Supercoiled
plasmids that migrated slower than linear 12-kb marker DNA were then
used to transform E. coli DH5, and the plasmids tested by restriction diges-
tion, and grown in large scale. The resulting plasmids were named
pAdEasyCMV-YFP–AC8 and pAdEasyE1A-YFP–AC8. The plasmid DNAs
were digested with PacI to liberate the adenovirus chromosomes and used
to transfect (Jordan et al., 1996) 293 cells (Graham et al., 1977) to make vi-
ruses. Despite repeated attempts, no plaques were isolated from cells
transfected with pAdEasyCMV-YFP–AC8. However, fluorescent plaques
were readily obtained from cells transfected with pAdEasyE1A-YFP–AC8,
suggesting that the level of overexpression of the YFP–AC8 gene that results
from the use of the CMV major immediate early promoter inhibited virus
production (Schaack et al., 2001). AdEasyE1A-YFP–AC8 virus was plaque
purified and grown in large scale using 293 cells, purified by successive
banding on CsCl step and isopycnic gradients, and dialyzed using three
changes of 10 mM Tris-HCl, pH 8.0, 135 mM NaCl, 1 mM MgCl2, 50%
vol/vol glycerol at 4 C. The particle concentration of the virus was quanti-AC6 and endothelial cell gap formation | Cioffi et al. 1277
tated by determination of the absorbance at 260 nm, where one A260 unit
was considered equal to 10
12 virus particles. The particle/plaque forming
unit ratio for viruses prepared in this manner is reproducibly close to
100:1. The virus was stored at  20 C.
Infection with adenovirus/AC8 construct
PMVECs were seeded onto 25-mm glass coverslips and grown to  60%
confluence, at which point they were infected with the adenoviral vector
constructed to express Ca
2 -stimulated AC8 at a titer of 100 plaque forming
units/cell. Initial studies using PAECs (unpublished data) and GH4C1 cells
established a dose-dependent increase in calcium-dependent cAMP syn-
thesis over a multiplicity of infection range from 0 to 200. A multiplicity of
infection of 100 provided reproducible calcium-stimulated cAMP re-
sponses and was therefore selected as the dose used in our present studies.
Cells were used 48 h after infection for cAMP measurement and videomi-
croscopy studies.
Calcium measurement
Calcium measurements and endothelial cell calibrations have been de-
scribed elsewhere (Stevens et al., 1994).
cAMP measurements
cAMP content was determined using a Biotrack cAMP competitive en-
zyme-immunoassay system (Amersham Pharmacia Biotech).
Confocal fluorescence microscopy
Fluorescent images were acquired on a Leica TCS SP2 confocal laser scan-
ning microscope at a 514-nm excitation. Slices were taken through cells at
0.5- m sections.
Time-lapsed fluorescence microscopy
40–48 h after infection with the YFP–AC8 construct, media was removed
from cells and replaced with Krebs/2 mM Ca
2  buffer. Fluorescent images
were acquired on an Olympus IX70 inverted microscope at 488-nm exci-
tation and processed using Spot Software (Diagnostic Instruments). Time-
lapse experiments were performed using the MetaMorph
® (Universal Imag-
ing Corp.) system. Images were collected at 40-s intervals over 30 min.
Online supplemental material
Supplemental videos are available at http://www.jcb.org/cgi/content/full/
jcb.200204022/DC1. Videos 1–3 are time-compressed movies of PMVECs,
demonstrating that thrombin-induced gap formation occurs only when
arise in [Ca
2 ] reduces cAMP. Videos 4–6 illustrate localization of AC
(YFP–AC8) primarily at sites of cell–cell adhesion.
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